Bimatoprost, timolol

Sold as Ganfort, Bimagam fort, Bimapres fort, Lobimopt, Timpromat, Timatear, Glauptico, Icobimil, Bimatoprost co adco, Ganfort ud

S4Read from the PI-PIL document and verified

C₁₃H₂₄N₄O₃S316.42 g/mol

(2S)-1-(tert-Butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol

Drag to rotate. Structure from PubChem CID 33624.

Loading Wikipedia summary

Registration

Applicants: 5
Registrations: 10
Schedule source: SAHPRA documentation

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Abbvie (Pty) Ltd	Ganfort, Ganfort ud	0,3 mg/ml	420127, 590079	Not determined	PI PIL
Austell Pharmaceuticals (Pty) Ltd	Bimagam fort, Bimapres fort	0,3 mg/mL and 5 mg/mL	540321, 540322.321	S4	PI PIL
Trinity Pharma (Pty) Ltd	Lobimopt, Timpromat, Timatear	5 mg, 0,3 mg	540388, 540389.388, 540390.388	S4	PI PIL
Gen-eye (Pty) Ltd	Glauptico	Not stated	560781	Not determined	None
Adcock ingram limited	Icobimil, Bimatoprost co adco	Not stated	560845, 560846.845	Not determined	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Ganfort EACH 1,0 ml SOLUTION CONTAINS: BIMATOPROST 0,3 mg,TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg	0,3 mg/mlEye drops, solution	42012742/15.4/0127Approved 21 April 2023	Registered	Not determined	PI PIL
Bimagam fort EACH 1,0 ml CREAM CONTAINS BIMATOPROST 0,3 mg TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg	0,3 mg/mL and 5 mg/mLEye drops, solution	54032154/15.4/0321Approved 3 October 2023	Registered	S4	PI PIL
Bimapres fort EACH 1,0 ml SOLUTION CONTAINS BIMATOPROST 0,3 mg TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg	0,3 mg/mL and 5 mg/mLEye drops, solution	540322.32154/15.4/0322.321Approved 3 October 2023	Registered	S4	PI PIL
Lobimopt EACH 1,0 ml SOLUTION CONTAINS TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg BIMATOPROST 3,0 mg	5 mg, 0,3 mgEye drop	54038854/15.4/0388Approved 11 April 2023	Registered	S4	PI PIL
Timpromat EACH 1,0 ml SOLUTION CONTAINS TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg BIMATOPROST 3,0 mg	5 mg, 0,3 mgEye drop	540389.38854/15.4/0389.388Approved 11 April 2023	Registered	S4	PI PIL
Timatear EACH 1,0 ml SOLUTION CONTAINS TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg BIMATOPROST 3,0 mg	5 mg, 0,3 mgEye drop	540390.38854/15.4/0390.388Approved 11 April 2023	Registered	S4	PI PIL
Glauptico EACH 1,0 ml SOLUTION CONTAINS BIMATOPROST 0,3 mg TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg	Not listed	56078156/15.4/0781	Registered	Not determined	None
Icobimil EACH 1,0 ml SOLUTION CONTAINS BIMATOPROST 0,3 mg TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg	Not listed	56084556/15.4/0845	Registered	Not determined	None
Bimatoprost co adco EACH 1,0 ml SOLUTION CONTAINS BIMATOPROST 0,3 mg TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg	Not listed	560846.84556/15.4/0846.845	Registered	Not determined	None
Ganfort ud EACH 1,0 ml SOLUTION CONTAINS: BIMATOPROST 0,3 mg TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg	Not listed	59007959/15.4/0079	Registered	Not determined	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Bimatoprost, timolol maleate equivalent to timolol

S4: Bimatoprost
Consolidated Schedules 06 July 2026, line 5499
S4: Latanoprost
Consolidated Schedules 06 July 2026, line 6878
S4: Travoprost
Consolidated Schedules 06 July 2026, line 8272
S3: Brinzolamide
Consolidated Schedules 06 July 2026, line 3235
S3: Dorzolamide
Consolidated Schedules 06 July 2026, line 3486
S3: Timolol
Consolidated Schedules 06 July 2026, line 4325

Pharmacological class: Others. (class 15.4)

Matched through the components Bimatoprost, Dorzolamide, Latanoprost, Brinzolamide, Travoprost.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsGanfort, Abbvie (Pty) Ltd Patient information leaflet (PIL)For patients and carersGanfort, Abbvie (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background